Product NDC: | 0378-3530 |
Proprietary Name: | Mirtazapine |
Non Proprietary Name: | Mirtazapine |
Active Ingredient(s): | 30 mg/1 & nbsp; Mirtazapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-3530 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076122 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121228 |
Package NDC: | 0378-3530-93 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3530-93) |
NDC Code | 0378-3530-93 |
Proprietary Name | Mirtazapine |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3530-93) |
Product NDC | 0378-3530 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mirtazapine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20121228 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | MIRTAZAPINE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes |